Firefly Neuroscience (AIFF) Net Income towards Common Stockholders (2010 - 2026)

Firefly Neuroscience has reported Net Income towards Common Stockholders for 16 years, with the latest figure at -$2.0 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 8.24% year-over-year to -$2.0 million in Q2 2026; TTM through Jun 2026 was -$9.4 million, a 66.58% increase from a year earlier, with the FY2025 full-year figure at -$24.5 million, down 134.52% from the prior year.
• Net Income towards Common Stockholders was -$2.0 million for Q2 2026 at Firefly Neuroscience, up from -$2.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $456438.0 in Q2 2023, with the low at -$17.3 million in Q1 2025.
• Average Net Income towards Common Stockholders over 5 years is -$3.3 million, with a median of -$2.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 4820.62% in 2022, then jumped 129.92% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at -$7.5 million in 2022, then jumped by 95.22% to -$358000.0 in 2023, then sank by 1764.53% to -$6.7 million in 2024, then surged by 59.27% to -$2.7 million in 2025, then climbed by 27.03% to -$2.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.0 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.